Fas Ligand (FasL) can induce apoptosis of Fas-bearing cells. It is expresse
d on the cell surface of many tumor cells, immune-privileged tissues and ac
tivated lymphocytes. We report here that Fast can itself transduce signals,
leading to cell-cycle arrest and cell death in CD4(+) T cells. In vitro, F
ast engagement inhibited CD4(+) T-cell proliferation, cell-cycle progressio
n, and IL-2 secretion. In vivo, FasL engagement prevented superantigen-medi
ated CD4(+), but not CD8(+), T-cell expansion. These findings demonstrate t
hat FasL engagement regulates cell-cycle progression, and show that FasL en
gagement in vivo has a potent anti-inflammatory effect specific for CD4(+)
T cells.